BRAF (B-raf proto-oncogene), CTNNB1 (Catenin (cadherin-associated protein), beta 1), EGFR (Epidermal growth factor receptor), FBXW7 (F-Box And WD Repeat Domain Containing 7), GNAS (GNAS Complex Locus), HER-2 (Human epidermal growth factor receptor 2)
See More ...
BRAF (B-raf proto-oncogene), CTNNB1 (Catenin (cadherin-associated protein), beta 1), EGFR (Epidermal growth factor receptor), FBXW7 (F-Box And WD Repeat Domain Containing 7), GNAS (GNAS Complex Locus), HER-2 (Human epidermal growth factor receptor 2), KMT2C (Lysine Methyltransferase 2C), KMT2D (Lysine Methyltransferase 2D), KRAS (KRAS proto-oncogene GTPase), MET (MET proto-oncogene, receptor tyrosine kinase), MLH1 (MutL homolog 1), MLH3 (MutL homolog 3), MSH2 (MutS Homolog 2), MSH3 (MutS Homolog 3), MSH6 (MutS homolog 6), MTHFR (Methylenetetrahydrofolate Reductase), MYC (V-myc avian myelocytomatosis viral oncogene homolog), NF1 (Neurofibromin 1), NF2 (Neurofibromin 2), NOTCH1 (Notch 1), NPM1 (Nucleophosmin 1), NRAS (Neuroblastoma RAS viral oncogene homolog), PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PMS1 (PMS1 protein homolog 1), PMS2 (PMS1 protein homolog 2), POLE (DNA Polymerase Epsilon), PTEN (Phosphatase and tensin homolog), PVT1 (Pvt1 Oncogene), RNF43 (Ring Finger Protein 43), SMAD4 (SMAD family member 4), STK11 (Serine/threonine kinase 11), VEGFA (Vascular endothelial growth factor A), ZFHX3 (Zinc Finger Homeobox 3)